Immunogenicity of COVID-19 vaccination in immunocompromised patients: an observational, prospective cohort study interim analysis
G Haidar, M Agha, A Lukanski, K Linstrum, R Troyan… - MedRxiv, 2021 - medrxiv.org
Objectives Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …
[PDF][PDF] Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort
AL DNPc, KL MSd, RT MBAc, A Bilderback - Chest, 1994 - natap.org
Objectives: Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …
[PDF][PDF] Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort
AL DNPc, KL MSd, RT MBAc, A Bilderback - Chest, 1994 - researchgate.net
Objectives: Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …
[PDF][PDF] Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort
AL DNPc, KL MSd, RT MBAc, A Bilderback - Chest, 1994 - natap.org
Objectives: Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis
G Haidar, M Agha, A Lukanski, K Linstrum, R Troyan… - 2021 - europepmc.org
Objectives Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …
[PDF][PDF] Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort
AL DNPc, KL MSd, RT MBAc, A Bilderback - Chest, 1994 - scholar.archive.org
Objectives: Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …
trials. The objectives of the study were to measure antibody responses, levels, and …